Lieberman/Hatch Bill Offers Incentives For Countermeasure Development
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics companies conducting bioterrorism countermeasure research are given a choice of four types of tax incentives for capital formulation under the "Biological, Chemical & Radiological Weapons Countermeasures Research Act" of 2003
You may also be interested in...
Project BioShield Should Exempt Device Firms From Liability – AdvaMed
Liability protections under Project BioShield should be extended to companies that make countermeasure devices and diagnostics available in an emergency situation, AdvaMed says
Project BioShield Mandatory Funding Meets Resistance In House
A White House plan to establish a permanent HHS funding stream to contract for bioweapon countermeasures ran into unexpected criticism from a bipartisan group of lawmakers March 27
Project BioShield Should Exempt Device Firms From Liability – AdvaMed
Liability protections under Project BioShield should be extended to companies that make countermeasure devices and diagnostics available in an emergency situation, AdvaMed says